IPO13 (Gene)

Entrez Gene ID: 9670

Description: importin 13

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View IPO13's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with IPO13.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using IPO13.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for IPO13.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with IPO13.

Gene Sets (2234)

LINCS L1000 Chem Pert Consensus Sigs (1099)

A gene set library provided by LINCS

ARCHS4 IDG Coexp (4)

A gene set library provided by IDG

LINCS L1000 CRISPR KO Consensus Sigs (1131)

A gene set library provided by LINCS

Knowledge Graph Assertions

Source	Relation	Target	Evidence
Enrofloxacin Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	IPO13 Gene (Entity type)	0.0075846883
cabergoline Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	IPO13 Gene (Entity type)	0.0043759127
eugenitol Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	IPO13 Gene (Entity type)	-0.014069326
cinoxacin Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	IPO13 Gene (Entity type)	-0.0049103172
KU-C104129 Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	IPO13 Gene (Entity type)	-0.01130911
1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	IPO13 Gene (Entity type)	0.003352239
tropisetron Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	IPO13 Gene (Entity type)	-0.00648828
Epidepride Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	IPO13 Gene (Entity type)	0.016222775
KDM-103 Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	IPO13 Gene (Entity type)	0.017238043
N-oleoylethanolamine Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	IPO13 Gene (Entity type)	-0.0045502805

Enrofloxacin
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
IPO13
Gene (Entity type)
0.0075846883

cabergoline
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
IPO13
Gene (Entity type)
0.0043759127

eugenitol
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
IPO13
Gene (Entity type)
-0.014069326

cinoxacin
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
IPO13
Gene (Entity type)
-0.0049103172

KU-C104129
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
IPO13
Gene (Entity type)
-0.01130911

1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
IPO13
Gene (Entity type)
0.003352239

tropisetron
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
IPO13
Gene (Entity type)
-0.00648828

Epidepride
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
IPO13
Gene (Entity type)
0.016222775

KDM-103
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
IPO13
Gene (Entity type)
0.017238043

N-oleoylethanolamine
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
IPO13
Gene (Entity type)
-0.0045502805

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.